Sections & Workgroups > Associated Section on Pharma Medical Biotechnology (EAPB)

Associated Section on Pharma Medical Biotechnology (EAPB)

The European Association of Pharma Biotechnology (EAPB), the Associated Section on Pharma Medical Biotechnology of the EFB, is a professional association dedicated to the advancement of biotechnology in pharmaceutical sciences, specifically as applied to industrial materials, processes, products and their associated problems. Its members constitute scientists employed in industry, government and university laboratories, biotech companies and scientific organizations.

During the 10th European Congress on Biotechnology in Madrid, July 2001, the idea was born to join forces of EFB and EAPB (European Association of Pharma Biotechnology). A cooperation agreement was formulated and adopted in October 2001.

EAPB is the representative and central network to promote and develop Pharma Biotechnology in Europe, linking academia, industries and regulatory bodies. Members are scientists (individual membership), companies, departments of companies and organisations from academia (corporate membership), but also industry, especially pharmaceutical industry and related sciences involved in pharma biotechnology.

For further information regarding this Associated Section, please visit the EAPB website or contact:

Dr. Sven Stegemann (Chairman)
Capsugel Bornem
Rijksweg 11
B-2880 Bornem
Phone +49 - 172 605 4869
Fax +41 - 61 705 5118
E-mail: sven.stegemann@pfizer.com